On June 18th, US Food & Drug Administration granted China’s Jiangsu Bioperfectus Technologies an Emergency Use Authorization for its COVID-19 Coronavirus Real-Time PCR Kit.
09 July 2020，Jiangsu Bioperfectus Technologies Co.,Ltd COVID-19 Coronavirus Real Time PCR Kit (product code JC10223-1NW-50T) was listed on World Health Organization Emergency Use Listing for In vitro diagnostics (IVDs) detecting SARS-CoV-2.
Bioperfectus Assisting Myanmar Government in Fighting Against the Pandemic
As large-scale COVID-19 vaccination will be an important undertaking
The new strain VUI 202012/01 of SARS-CoV-2 (also known as B.1.1.7 lineage) has recently caused the panic around the globe.
As the panic caused by the variant of COVID-19 is spreading to the world originating from Britain
As the COVID-19 pandemic is widely spreading in Africa, the Africa CDC had issued the Interim Guidance on the Use of Rapid Antigen tests for COVID-19 Response
Bioperfectus COVID-19 Coronavirus and Influenza A/B Virus Real Time PCR Kit is developed on the purpose to efficiently cope with the "twindemic"
The Antibody, also known as immunoglobulin, is a Y-shaped protein used by the immune system
Bioperfectus provides a complete solution including the Nucleic Acid Extraction System of 3 different models (32 channels/64 channels/96 channels) and extraction kits.
Copyright © 2010-2022 Jiangsu Bioperfectus Technologies Co., Ltd All Rights Reserved.
Tel: +86 021-5484 7326